News
News
Upcoming Events
Subscribe
Our Company
Our Story
Our Vision
Board of Directors
Alzinova Team
Advisers & Collaborators
Patients & Families
Alzheimer's Patients
Impact on Society
The Unmet Medical Need
R & D
Alzheimer's Disease
Our Programs
Specific Targeting of Toxic Aβ Oligomers
The AβCC Peptide™ Technology
Scientific Presentations
Investors
Overview
Press Releases
English
Swedish
Subscribe
Rights Issue 2024
Presentations
Board and Management
The Share
Financial Reports
Financial Reports - English
Financial Reports – Swedish
Financial Calendar
Corporate Governance
General Meetings
IR Contact
Career
Contact
News
News
Upcoming Events
Subscribe
Our Company
Our Story
Our Vision
Board of Directors
Alzinova Team
Advisers & Collaborators
Patients & Families
Alzheimer's Patients
Impact on Society
The Unmet Medical Need
R & D
Alzheimer's Disease
Our Programs
Specific Targeting of Toxic Aβ Oligomers
The AβCC Peptide™ Technology
Scientific Presentations
Investors
Overview
Press Releases
English
Swedish
Subscribe
Rights Issue 2024
Presentations
Board and Management
The Share
Financial Reports
Financial Reports - English
Financial Reports – Swedish
Financial Calendar
Corporate Governance
General Meetings
IR Contact
Career
Contact
Home
/
Investors
/
Pressreleaser
Overview
Press Releases
English
Swedish
Subscribe
Rights Issue 2024
Presentations
Board and Management
The Share
Financial Reports
Financial Reports - English
Financial Reports – Swedish
Financial Calendar
Corporate Governance
General Meetings
IR Contact
Pressreleaser
sv
/investors/press-releases-sv/press
